Table 2 Association between the uromodulin levels and the end-point events rates
From: Serum uromodulin and progression of kidney disease in patients with chronic kidney disease
Serum uromodulin tertiles (ng/mL) | Number of events | Events per 100 person-years | P for log-rank |
|---|---|---|---|
ESRD events | < 0.001 | ||
 ≤ 52.7 (N = 885) | 267 (30.17%) | 7.86 |  |
 > 52.7–100.8 (N = 881) | 106 (12.03%) | 2.80 |  |
 > 100.8 (N = 886) | 31 (3.50%) | 0.77 |  |
Total | 404 (15.23%) | 3.60 | Â |
Cardiovascular events | < 0.001 | ||
 ≤ 52.7 (N = 885) | 86 (9.72%) | 2.20 |  |
 > 52.7–100.8 (N = 881) | 63 (7.15%) | 1.62 |  |
 > 100.8 (N = 886) | 40 (4.51%) | 0.99 |  |
Total | 189 (7.13%) | 1.60 | Â |
All-cause mortality | 0.003 | ||
 ≤ 52.7 (N = 885) | 35 (3.95%) | 0.87 |  |
 > 52.7–100.8 (N = 881) | 22 (2.50%) | 0.55 |  |
 > 100.8 (N = 886) | 12 (1.35%) | 0.29 |  |
Total | 69 (2.60%) | 0.57 | Â |